Avino Silver & Gold Mines Reappoints Hichem M’Saad as CEO for Second Term

ASM
December 09, 2025

Avino Silver & Gold Mines Ltd. (ASM) has confirmed that Hichem M’Saad will continue as chief executive officer for a second four‑year term, extending his leadership through 2029. M’Saad was appointed CEO in May 2024, following his earlier role on the management board since 2022, and the reappointment solidifies continuity at the helm of the company’s growth strategy.

The Supervisory Board also reappointed Marc de Jong for a two‑year term and announced that Chair Pauline van der Meer Mohr will retire at the 2027 annual general meeting, allowing the board to begin succession planning while maintaining experienced oversight.

Under M’Saad’s leadership, ASM delivered record financial results in the third quarter of 2025. Revenue rose 44% to $21.0 million, driven by a 21% increase in mill throughput compared with Q3 2024, while net income surged 559% to $7.7 million. Cash costs per silver‑equivalent payable ounce sold fell 8% year‑over‑year, reflecting disciplined cost management and operational efficiencies.

These results reinforce ASM’s strategy to become a mid‑tier producer through the expansion of the La Preciosa project. The company’s debt‑free balance sheet and growing cash reserves provide a strong foundation for self‑funded growth, while the operational gains demonstrate the scalability of its mining and processing operations.

The Supervisory Board’s endorsement of M’Saad’s reappointment signals confidence in his execution of the company’s growth plan. Board members highlighted his track record of improving margins, scaling throughput, and maintaining a disciplined cost base, underscoring the board’s belief that continuity will support the next phase of ASM’s development.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.